The U.S. Food and Drug Administration (FDA) have cleared the Verax Biomedical manufactured Platelet PGD Test System for marketing.

Platelet PGD Test System is the first rapid test for the detection of bacterial contamination in pooled platelets derived from whole blood. Patients who are transfused with contaminated platelets bear the risk of developing serious infections. It is therefore important to detect and interdict such contamination before transfusion. 

The Platelet PGD Test System consists of a single-use test strip that, in fewer than 60 minutes, produces a signal that indicates the presence of bacteria.  The test is intended for use mainly by hospital transfusion services as a quality control test for the detection of bacteria just prior to a patient blood transfusion.

Read more


 

More news

(2011-12-21)
(2011-07-08)
(2011-02-28)
(2010-12-21)
(2010-11-30)
(2010-11-26)
(2010-11-22)
(2010-09-20)
(2010-06-17)
(2010-03-19)
(2009-08-21)
(2007-05-09)
 
 
News type
 
 

Latest PE Voice

Harald Mix on Nordic private equity

- 1/10/2012 10:10:00 AM
At the Argentum Conference in 2010, we asked Harald Mix, Managing Partner and Co-founder of Altor Equity Partners about the outlook for future returns in Nordic private equity.
 
 

Calendar

2012-02-07 in Stockholm

Limited Partners Brief 2012

2012-02-07 in London

LP-GP Forum Clean Energy & Sustainability

2012-02-16 in Bergen

Vestlandskonferansen

2012-02-27 in Berlin

SuperReturn International 2012

2012-03-05 in Copenhagen

Nordic Fundraising Summit
 
Copyright Argentum 2009